PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · Oct 2, 2026
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent DirectorGlobeNewsWire · Sep 21, 2026
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership TransitionGlobeNewsWire · Sep 17, 2026
PetMeds Appoints Andrew Parry as Chief Technology OfficerGlobeNewsWire · Sep 14, 2026
Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)Defense World · Sep 10, 2026
PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/YZacks Investment Research · Aug 14, 2026PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | $0.12 | -$0.28 | Miss |
| Jun 2, 2026 | -$0.18 | -$0.19 | Miss |
| Feb 5, 2026 | -$0.06 | -$0.50 | Miss |
| Dec 19, 2025 | -$0.02 | -$0.34 | Miss |
| Sep 30, 2025 | -$0.06 | -$0.07 | Miss |
| Aug 26, 2025 | -$0.06 | -$0.49 | Miss |